Home > Companies > Silenseed
Last Update 6.10.2021Edit Profile
Silenseed logo
Silenseed
RNAi-based Cancer Drugs and Delivery Systems
Non Visible
 
http://silenseed.com

About

Silenseed is a clinical-stage biopharmaceutical company that is using a proprietary RNA interference strategy to develop cancer drugs and delivery systems designed to effectively penetrate and treat malignant solid tumors. The companys novel drugs, combined with the local drug eluter (LODER) delivery system, have the potential to become an effective treatment for solid tumor cancers. Silenseed is focused on treatments for pancreatic cancer, prostate cancer, and certain brain cancers. Silenseed has completed a phase 2a clinical study for pancreatic cancer which showed promising results.

Founded

11/2008

Business models

B2B

Employees

11-50

Product stage

Clinical Trial

Products

siG12D-LODER, Prostate-LODER, GBM-LODER, Protact, KRAS-LODER

Geographic markets

United States, China

Funding

Total Funding

$18.3M

Last Funding

$7.8M

Funding Stage

Revenue Financed

Total Rounds

4

Investors

3

The Team

(3)
ASP
Amotz Shemi, PhD
Co-Founder & CEO
EG
Eran Geffen
VP Business Development
EGM
Eitan Galun, MD
Co-Founder

Company Lifecycle

Event View
Timeline View

Public Offerings & Exits

Private Equity Funding

Seed
Apr 2014
1 Investors
$500K
Undisclosed Round
Aug 2017
1 Investors
$10M

Non-Equity Funding

Grant
Sep 2009
1 Investors
Undisclosed

Mergers and Acquisitions

Others

Use Cases (0)

Media gallery

(2)
Silenseed - Targeted Therapies for Solid Tumors logo
Silenseed - Targeted Therapies for Solid Tumors
 logo

Locations

Israel

HaMa'ayan Street 2, Modi'in-Maccabim-Re'ut, Israel

Offices Abroad

Sector

Life Sciences & HealthTech
Pharma & Biomedicine
Discovery & Development
Drug Delivery

Core Technology

Biologicals
Cells

Target Industry

Healthcare & Life Sciences
Life Sciences
Pharmaceuticals

Tags

(11)
biological-therapy cancer oncology orphan-drug drug-delivery rna pharmaceuticals nanotechnology prostate brain cancer-therapy

Target Markets

(1)
pharma-companies

Notes

Content Writer
undefined
BI Verification
undefined
Phone Number
undefined
Israel Register ID
undefined
Confidence Score
undefined
Missing Fields
undefined
Profile Creator
undefined
Profile Update
undefined
undefined
Data and visuals presented here may not be used without the written consent of Start-Up Nation Finder.
Copyright © 2022 Terms of Use Privacy Policy